CellenGene Achieves US Patent Approval for Breakthrough CAR-T Therapy Targeting Solid Tumors
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
Tag: CellenGene
CellenGene Selected for National New Drug Development Project, Advances CAR-T Therapy for Ovarian Cancer
CellenGene, a biotechnology company specializing in cell gene therapy (CEO: Ahn Jae-hyun), has been selected for the 'New Drug Ecosystem ...
Copyright © 2023 KoreaTechDesk | About Us
| Our Services| Terms of Use |Privacy Policy |Cookie Policy
Contact:
[email protected]
